| Original language | English (US) |
|---|---|
| Pages (from-to) | 512-514 |
| Number of pages | 3 |
| Journal | Diabetes care |
| Volume | 43 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1 2020 |
Bibliographical note
Funding Information:Funding. E.R.S. has funding from the National Institutes of Health National Institute of Neurological Disorders and Stroke (R01 NS035192) and JDRF (3-SRA-2017-483-S-B). Duality of Interest. E.R.S. has served as an advisor/consultant for Sanofi, Zucara, MannKind, and Eli Lilly. Her university has received grant funding from Eli Lilly for an investigator-initiated project developed and implemented by E.R.S. No other potential conflicts of interest relevant to this article were reported.
PubMed: MeSH publication types
- Journal Article
- Comment
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
UN SDGs
This output contributes to the following Sustainable Development Goal(s)
